Scientific deep-dive
Fat-to-Muscle Ratio: Surgery Versus Drugs
The lean-to-fat ratio improved in both groups at 6, 12 and 24 months. Everyone loses lean tissue when losing weight. The question is the mix, and both interventions improved it.
Most arguments about muscle loss count the wrong thing, the amount of lean tissue lost. What matters is the mix: how much lean comes off relative to fat. A cohort study measured exactly that after bariatric surgery and after semaglutide or tirzepatide, and the ratio improved in both groups at every time point.[1]
The numbers
| Time point | Bariatric surgery | GLP-1 receptor agonists |
|---|---|---|
| 6 months | 1.8 | 1.4 |
| 12 months | 2.1 | 1.5 |
| 24 months | 2.0 | 1.5 |
Both groups lost substantial fat mass and moderate fat-free mass, and both improved the ratio between them. Surgery maintained a higher ratio throughout.[1]
Why the comparison between columns is the weak part
This is a single-center cohort study, not a randomized comparison, and people who have bariatric surgery differ enormously from people prescribed a GLP-1. They differ in starting weight, in how long they have been trying, in what else has failed, and in the post-operative nutrition and follow-up programs that surgery carries with it.
Surgical patients also get nutritional follow-up as part of aftercare: the US perioperative guideline calls for a team approach “with special attention to nutritional and metabolic issues.”[3] That kind of support may help preserve lean mass. Some of that column difference may be the aftercare rather than the procedure. We cover the broader comparison in surgery versus GLP-1 drugs, including a widely quoted 28% against 10% weight figure that rests on 257 people in the drug arm.
Surgical aftercare includes nutritional follow-up,[3] so part of the gap between the columns may be the aftercare, not the operation.
The sex difference runs the other way
One stratified result points the opposite way from a better-known finding. Men preserved fat-free mass better than women, especially after GLP-1 treatment.[1]
Women, meanwhile, lose a larger percentage of body weight on these drugs: 10.9% against 6.8% across the six trials that reported results by sex in a 64-trial review,[2] covered in who loses more weight. The two findings do not contradict each other. One is about how much total weight comes off, the other about what that weight is made of.
Either way, the advice is the same: resistance training, which has randomized support for changing the mix, and adequate protein. Our lean mass article has the figures, and protein targets covers how much to eat.
Frequently Asked Questions
References
- 1.Wang Z, Wang L, Zhang X, et al. Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists JAMA Network Open. 2026. PMID: 41511769.
- 2.Alexander GC, Xiao X, Dilek S, et al. Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis JAMA Internal Medicine. 2026. PMID: 41770554.
- 3.Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists Surg Obes Relat Dis. 2020. PMID: 31917200.
Compare the sellers
Related research
The Day the Balloon Comes Out
An intragastric balloon is removed on a scheduled date, which makes it an unusually clean experiment in what happens when a weight intervention ends. One group began regaining. The other kept losing.
6 min read
The Group That Lost Least Did Best
A study compared surgery, semaglutide and a lifestyle program in young women with endometrial cancer. The group that lost the least weight had the highest tumor remission rate, and that is almost certainly not what it looks like.
6 min read
The Weight Comparison Used 257 People
A 30,458-patient study reported surgery producing 28.3% weight loss against 10.3% on GLP-1s, at lower two-year cost. The cost half uses the whole cohort. The weight half uses 1.6% of one arm.
7 min read
The Line Is Drawn by Surgery
A meta-regression found study arms with greater average weight loss had higher rates of fatty liver disease resolving. The authors say plainly it cannot establish cause, and a handful of surgical arms are pulling the line.
6 min read
Surgery Versus GLP-1 Drugs: Reading an Indirect Comparison
A network meta-analysis of 30 trials put surgery about 10 points ahead on total weight loss. Nobody was randomized to surgery versus a drug, and against tirzepatide alone the difference vanished.
6 min read
When Is It Safe to Have the Skin Removed?
Large weight loss leaves skin that does not retract. A review of 12 studies puts the weight plateau at 53 weeks, and the more consequential finding is about what happens if you stop the drug afterward.
6 min read
Where to get GLP-1 online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
YourEra
Semaglutide at $99/month, well below the typical price
From $99/mo
Get started →Eden
Coverage in all 50 states, which most sellers will not confirm
From $99/mo
Get started →Found
People who want clinician visits billed to commercial insurance, with compounded medication in the plan price
From $149/mo + membership
Get started →